2014/4 GaBI Journal Table of Contents

Published in: Volume 3 / Year 2014 / Issue 4
Category: 2014/4 GaBI Journal Table of Contents
Visits: 2535 total, 1 today

Contents

Editor’s Letter

Fourth and final issue of GaBI Journal’s third volume

Editorial

Availability and procurement of generics in hospitals among medium-sized European countries

Letters to the Editor

Access to alternative biopharmaceuticals in low- and middle- income countries

Commentary

Biosimilars versus ‘biobetters’ — a regulator’s perspective

Original Research

Availability and procurement conditions of originator and generic medicines in hospitals – an exploratory study in five medium-sized European countries

Review Article

Safety assessment of biosimilars in Europe: a regulatory perspective

Opinion

Is Australia positioned to take advantage of biosimilars?

Tell me the whole story: the role of product labelling in building user confidence in biosimilars in Europe

Regulatory

Regulation of biologicals in Malaysia

Meeting Report

2014 World Transplant Congress, San Francisco, California, USA, 26–31 July 2014

Interview

Amgen’s move into the biosimilars market

Pharma News

International Alliance of Patients’ Organizations toolkit for biological and biosimilar medicines

Reducing the European healthcare budget with generics and biosimilars

Abstracted Scientific Content

Pharmaceutical policy interventions in times of economic recession

Go Back Print

Leave a Reply